Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction:: Role of memory B cells and CD5+ B cells

被引:77
|
作者
Blanca, IR
Bere, EW
Young, HA
Ortaldo, JR
机构
[1] NCI, Frederick Canc Res & Dev Ctr, Expt Immunol Lab, Frederick, MD 21702 USA
[2] Cent Univ Venezuela, Fac Med, Inst Inmunol, Caracas, Venezuela
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 11期
关键词
D O I
10.4049/jimmunol.167.11.6132
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NK cells are a subpopulation of lymphocytes characterized primarily by their cytolytic activity. They are recognized as an important component of the immune response against virus infection and tumors. In addition to their cytolytic activity, NK cells also participate either directly or indirectly in the regulation of the ongoing Ab response. More recently, it has been suggested that NK cells have an important role in the outcome of autoimmune diseases. Here, we demonstrate that human NK cells can induce autologous resting B cells to synthesize Ig, including switching to IgG and IgA, reminiscent of a secondary Ab response. B cell activation by the NK cell is contact-dependent and rapid, suggesting an autocrine B cell-regulated process. This NK cell function is T cell-independent, requires an active cytoplasmic membrane, and is blocked by anti-CD40 ligand (anti-CD154) or CD40-mIg fusion protein, indicating a critical role for CD40-CD40 ligand interaction. Depletion studies also demonstrate that CD5(+) B cells (autoreactive B-1 cells) and a heterogeneous population of CD27(+) memory B cells play a critical role in the Ig response induced by NK cells. The existence of this novel mechanism of B cell activation has important implications in innate immunity, B cell-mediated autoimmunity, and B cell neoplasia.
引用
收藏
页码:6132 / 6139
页数:8
相关论文
共 50 条
  • [21] Activated platelets induce tissue factor expression in human monocyte cells independent of CD40-CD40 ligand interaction
    Tenno, T
    Lindmark, E
    Slegbahn, A
    THROMBOSIS AND HAEMOSTASIS, 1999, : 411 - 411
  • [22] Th2-dependent B cell responses in the absence of CD40-CD40 ligand interactions
    Chirmule, N
    Tazelaar, J
    Wilson, JM
    JOURNAL OF IMMUNOLOGY, 2000, 164 (01): : 248 - 255
  • [23] CD5+ B cells are preferentially expanded in rabbit appendix:: The role of CD5 in B cell development and selection
    Pospisil, Richard
    Alexander, Cornelius B.
    Obiakor, Harold
    Sinha, Rajesh K.
    Mage, Rose G.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2006, 30 (08): : 711 - 722
  • [24] CD40 PLAYS AN ESSENTIAL ROLE IN THE ACTIVATION OF HUMAN B-CELLS BY MURINE EL4B5 CELLS
    KWEKKEBOOM, J
    DEBOER, M
    TAGER, JM
    DEGROOT, C
    IMMUNOLOGY, 1993, 79 (03) : 439 - 444
  • [25] THE CD40 LIGAND EXPRESSED BY HUMAN B-CELLS COSTIMULATES B-CELL RESPONSES
    GRAMMER, AC
    BERGMAN, MC
    MIURA, Y
    FUJITA, K
    DAVIS, LS
    LIPSKY, PE
    JOURNAL OF IMMUNOLOGY, 1995, 154 (10): : 4996 - 5010
  • [26] Change in activation status of circulating CD5+ and CD5- human B cells during aging
    Danile, RN
    Sison, CP
    Chiorazzi, N
    FASEB JOURNAL, 2003, 17 (07): : C92 - C92
  • [27] Activation and regulation of the IκB kinase in human B cells by CD40 signaling
    Kosaka, Y
    Calderhead, DM
    Manning, EM
    Hambor, JE
    Black, A
    Geleziunas, R
    Marcu, KB
    Noelle, RJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (04) : 1353 - 1362
  • [28] Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key
    Bachmann, MF
    Hunziker, L
    Zinkernagel, RM
    Storni, T
    Kopf, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) : 317 - 326
  • [29] The role of the CD40 antigen on malignant B cells
    Planken, EV
    Willemze, R
    KluinNelemans, JC
    LEUKEMIA & LYMPHOMA, 1996, 22 (3-4) : 229 - 235
  • [30] CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection
    Jones, ND
    Van Maurik, A
    Hara, M
    Spriewald, BM
    Witzke, O
    Morris, PJ
    Wood, KJ
    JOURNAL OF IMMUNOLOGY, 2000, 165 (02): : 1111 - 1118